Iran Emerges as World’s Second-Largest Producer of Innovative ‘Tilmanocept’ Cancer Tracer

Iran Emerges as World’s Second-Largest Producer of Innovative ‘Tilmanocept’ Cancer Tracer

In a groundbreaking achievement, an Iranian knowledge-based company has developed a new method for synthesizing Technetium (99mTc) tilmanocept, a crucial radiopharmaceutical diagnostic imaging agent. This innovative product is designed to aid in the identification of lymph nodes that may be draining from tumors, significantly impacting cancer treatment strategies.

Since 2013, the United States has stood as the sole manufacturer of this vital radiopharmaceutical agent, as reported by IRNA. The lymphatic system plays a critical role in cancer metastasis, making accurate detection of lymph node involvement essential for effective surgical intervention, particularly in patients diagnosed with breast, lung, and genital tract cancers.

Without timely identification of affected lymph nodes, surgeons may resort to removing large sections of the lymphatic system. This invasive procedure can lead to numerous side effects and severely compromise a patient’s immune system and blood circulation. The newly developed radiodiagnostic agent will assist healthcare professionals in pinpointing lymph nodes for removal, thus preserving healthy lymphatic tissue and reducing unnecessary surgeries and complications.

Thanks to this remarkable advancement, approximately 90 percent of cancer patients in Iran will have access to a more affordable and accurate diagnostic and treatment method. The drug has successfully progressed through preclinical phases and is now in the clinical trial stage.

Cancer remains one of the most pressing global health challenges, impacting millions of individuals each year. According to the Iranian Health Ministry, cancers are the leading cause of premature mortality in the country, contributing to over 55,000 deaths annually. Of these, around 34,000 deaths occur among those under 70 years, and 11,000 among those under 50 years of age, resulting from various cancer types.

The latest national cancer census indicates a concerning trend, with new cancer cases in Iran projected to rise to 160,000 by the Iranian calendar year 1404 (March 2025-March 2026), representing a 43 percent increase. The ten most common cancers in Iran include:

  • Breast Cancer
  • Prostate Cancer
  • Colon Cancer
  • Stomach Cancer
  • Lung Cancer
  • Bladder Cancer
  • Thyroid Cancer
  • Uterine Cancer
  • Brain Cancer
  • Spinal Cancer

For Iranian women, the most prevalent cancers consist of:

  • Breast Cancer
  • Colon Cancer
  • Thyroid Cancer
  • Stomach Cancer
  • Uterine Cancer
  • Leukemia
  • Ovarian Cancer
  • Brain Cancer
  • Spinal Cancer
  • Lung Cancer
  • Esophageal Cancer

Currently, around 250,000 Iranians are living with cancer. It is noteworthy that nearly half of all cancers can be treated effectively, while the remainder can often be prevented.

Recent Achievements in Cancer Research

On January 20, 2024, the Iran University of Medical Sciences (IUMS) announced the development of an artificial intelligence (AI)-based system capable of detecting breast cancer with a remarkable 94 percent accuracy, as reported by IRNA. Breast cancer is the second leading cause of mortality among women in Iran, with approximately 30 percent of patients succumbing to the disease each year, aligning closely with the global average.

Early detection is crucial as it significantly enhances the chances of successful treatment and survival. In addition, an Iranian knowledge-based company has expressed readiness to fulfill the demand for the human papillomavirus (HPV) vaccine across regional countries and North Africa. This vaccine is essential as HPV is a known cause of cervical cancer in women.

The HPV vaccine has been produced at a substantially reduced cost, being 75 percent cheaper than foreign alternatives. Manufacturing the HPV vaccine involves one of the most intricate technologies globally, yet Iran has successfully developed this vaccine domestically. Following rigorous safety and efficacy trials, the vaccine received approval from the Food and Drug Organization in 2020.

In a notable achievement for cancer treatment, an Iranian knowledge-based company successfully produced ibrutinib, a medication used to treat various blood cancers, positioning Iran as the third country in the world capable of producing this advanced treatment. Now, Iran joins India and China as the only nations with the expertise to manufacture ibrutinib and its necessary raw materials, according to IRNA.

These advancements in cancer treatment and diagnosis signify a pivotal moment for healthcare in Iran, promising better outcomes for patients and a brighter future in the fight against cancer.

Similar Posts

  • Iran Sees 5% Surge in Non-Oil Exports to Europe Over 11 Months

    In 2024, trade between Iran and the European Union saw a slight decline, totaling €4.150 billion from January to November, a 3% drop compared to the previous year. November alone recorded €377 million, down from €467 million in November 2023. Germany remains Iran’s primary EU trading partner, followed by Italy, the Netherlands, and Belgium. Despite the decrease, the EU continues to be a crucial economic partner for Iran, highlighting the need for ongoing dialogue and collaboration amid geopolitical challenges and market fluctuations. The potential for future growth in trade exists, contingent on stability and cooperation between the regions.

  • Free Pneumococcal and Rotavirus Vaccinations for Infants Offered by Health Ministry!

    Iran has launched a significant public health initiative, providing free pneumococcal and rotavirus vaccinations for children at all medical centers nationwide. Deputy Health Minister Alireza Raeisi announced this program, which aims to prevent severe illnesses caused by these infections. The rotavirus vaccine is expected to prevent over 50,000 hospitalizations and 10,000 severe diarrhea cases annually, while the pneumococcal vaccine could avert 1,500 deaths and over 10,000 hospital admissions each year. The program, which includes domestic vaccine development, represents a major advancement in child health, with strong government support for immunization efforts.

  • Unleashing AI: Driving the Data Science Revolution in the Fourth Industrial Era

    The Fourth Industrial Revolution, centered on artificial intelligence (AI) and data science, is transforming industries by introducing intelligent systems that learn and make decisions autonomously. In manufacturing, AI enhances production through predictive maintenance, collaborative robots, and optimized supply chains. The finance sector benefits from real-time fraud detection, accurate credit assessments, and robo-advisors. Retail experiences improved customer experiences with personalized recommendations and efficient inventory management. However, challenges such as job displacement, data privacy, and ethical decision-making arise. To navigate these issues, the workforce must adapt with new skills, while collaboration among policymakers and industry leaders is crucial for responsible AI use.

  • This article will be expanded soon. This article will be expanded soon. This article will be expanded soon. This article will be expanded soon. This article will be expanded soon. This article will be expanded soon. This article will be expanded with more detailed information shortly. This article will be expanded with more detailed information…

  • Iran’s Naval Dominance: Top Commander Highlights Powerful Presence on High Seas

    Major General Baqeri announced Iran’s intention to operate in distant waters to secure its shipping routes, enhancing the country’s maritime security and regional power. During the induction of the Martyr Baqeri drone carrier into the Islamic Revolution Guard Corps Navy, he emphasized the importance of naval strength and self-sufficiency. The drone carrier can maintain security over vast areas and protect commercial interests. Baqeri reassured that Iran’s military expansion is not aimed at neighboring countries, promoting peace and cooperation. This strategic move signifies Iran’s commitment to safeguarding its maritime interests and influencing global maritime affairs while adhering to international laws.

  • 5G Internet Set to Launch in Iran’s Major Cities by March, Announces Minister

    Iran plans to launch 5G internet access in major cities by the end of the current Persian calendar year, as announced by Minister of Information and Communications Technology Sattar Hashemi. The rollout will prioritize urban areas, enhancing internet speeds and reliability, with potential download speeds reaching 500 Mbps. Key steps include auctioning radio frequencies and collaborating with South Korea to ensure compatibility with Samsung smartphones. This initiative aims to transform digital connectivity in Iran, benefiting various sectors like education and healthcare, while the number of 5G mast sites has risen significantly, supporting the anticipated demand for high-speed services.